Association between tobacco smoke exposure and levels of C-reactive protein in the Oslo II Study

European Journal of Epidemiology

Volumn 22, Issue 5, 2007, Pages 311-317

  Madsen, Christian ^a   Nafstad, Per ^a,b   Eikvar, Lars ^c   Schwarze, Per E ^a   Rønningen, Kjersti S ^a   Haaheim, Lise Lund ^d  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^d NORWEGIAN KNOWLEDGE CENTRE FOR THE HEALTH SERVICES   (Norway)

Author keywords

C reactive protein; Cardiovascular disease; Cross sectional study; Environmental exposure; Pack years of smoking; Tobacco smoke exposure

Indexed keywords

C REACTIVE PROTEIN; TOBACCO SMOKE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ATHEROGENESIS; CORONARY ARTERY ATHEROSCLEROSIS; DATA ANALYSIS; DEMOGRAPHY; DISEASE EXACERBATION; ENVIRONMENTAL EXPOSURE; FEMALE; HEALTH SURVEY; HUMAN; INDOOR AIR POLLUTION; MALE; PROTEIN BLOOD LEVEL; SCREENING TEST;

AGED; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; ENVIRONMENTAL EXPOSURE; HUMANS; MALE; MIDDLE AGED; NORWAY; SMOKING; TOBACCO SMOKE POLLUTION;

EID: 34249998882     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-007-9121-6     Document Type: Article

References (37)

1. Chen Z, Boreham J. Smoking and cardiovascular disease. Semin Vasc Med 2002;2:243-52
2. Kannel WB, D'Agostino RB, Belanger AJ. Fibrinogen, cigarette smoking, and risk of cardiovascular disease: insights from the Framingham Study. Am Heart J 1987;113:1006-10
3. Ludvig J, Miner B, Eisenberg MJ. Smoking cessation in patients with coronary artery disease. Am Heart J 2005;149:565-72
4. Miettinen OS, Neff RK, Jick H. Cigarette-smoking and nonfatal myocardial infarction: rate ratio in relation to age, sex and predisposing conditions. Am J Epidemiol 1976;103:30-6
5. Neaton JD,.Wentworth D. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research Group. Arch Intern Med 1992;152:56-64
6. Rosengren A, Wilhelmsen L, Wedel H. Coronary heart disease, cancer and mortality in male middle-aged light smokers. J Intern Med 1992;231:357-62
7. Steenland K, Thun M, Lally C, Heath C Jr. Environmental tobacco smoke and coronary heart disease in the American Cancer Society CPS-II cohort. Circulation 1996;94:622-8
8. Hermanson B, Omenn GS, Kronmal RA, Gersh BJ. Beneficial 6-year outcome of smoking cessation in older men and women with coronary artery disease. Results from the CASS registry. N Engl J Med 1988;319:1365-9
9. Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol 2004;43:1731-7
10. Tracy RP, Lemaitre RN, Psaty BM, Ives DG, Evans RW, Cushman M et al. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol 1997;17:1121-7
11. Rifai N,.Ridker PM. Inflammatory markers and coronary heart disease. Curr Opin Lipidol 2002;13:383-9
12. Ferreiros ER, Boissonnet CP, Pizarro R, Merletti PF, Corrado G, Cagide A et al. Independent prognostic value of elevated C-reactive protein in unstable angina. Circulation 1999;100:1958-63
13. Papanicolaou DA, Wilder RL, Manolagas SC, Chrousos GP. The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med 1998;128:127-37
14. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-9
15. Ridker PM, Rifai N, Pfeffer MA, Sacks F, Braunwald E. Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators. Circulation 1999;100:230-5
16. van Exel E, Gussekloo J, de Craen AJ. Bootsma-van der Wiel A, Frolich M, Westendorp RG. Inflammation and stroke: the Leiden 85-Plus Study. Stroke 2002;33:1135-8
17. Cushman M, Arnold AM, Psaty BM, Manolio TA, Kuller LH, Burke GL et al. C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the cardiovascular health study. Circulation 2005;112:25-31
18. Haheim LL, Lund Larsen PG, Sogaard AJ, Holme I. Risk factors associated with body mass index increase in men at 28 years follow-up. QJM 2006;99:665-71
19. Haheim LL, Holme I, Hjermann I, Leren P. Smoking habits and risk of fatal stroke: 18 years follow up of the Oslo Study. J Epidemiol Commu Health 1996;50:621-4
20. Torres JL, Ridker PM. High sensitivity C-reactive protein in clinical practice. Am Heart Hosp J 2003;1:207-11
21. Ridker PM. Cardiology Patient Page. C-reactive protein: a simple test to help predict risk of heart attack and stroke. Circulation 2003;108:e81-5
22. Walker SE, Slordal LH, Guerreiro C, Gram F, Gronskei KE. Air pollution exposure monitoring and estimation. Part II. Model evaluation and population exposure. J Environ Monit 1999;1:321-6
23. Oftedal B, Walker SE, Gram F, McInnes H, Nafstad P. Modelling long-term averages of local ambient air pollution in Oslo, Norway: evaluation of nitrogen dioxide, PM10 and PM2.5. Int J Environ Pollut 2006.
24. Bermudez EA, Rifai N, Buring JE, Manson JE, Ridker PM. Relation between markers of systemic vascular inflammation and smoking in women. Am J Cardiol 2002;89:1117-9
25. Rohde LE, Hennekens CH, Ridker PM. Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men. Am J Cardiol 1999;84:1018-22
26. Donaldson K, Stone V, Seaton A, MacNee W. Ambient particle inhalation and the cardiovascular system: potential mechanisms. Environ Health Perspect 2001;109(Suppl 4):523-7
27. Seaton A, Soutar A, Crawford V, Elton R, McNerlan S, Cherrie J et al. Particulate air pollution and the blood. Thorax 1999;54:1027-32
28. Maraldi C, Volpato S, Kritchevsky SB, Cesari M, Andresen E, Leeuwenburgh C et al. Impact of inflammation on the relationship among alcohol consumption, mortality, and cardiac events: the health, aging, and body composition study. Arch Intern Med 2006;166:1490-7
29. Prasad K. C-reactive protein and cardiovascular diseases. IntI J Angiol 2003;1-12
30. Vigushin DM, Pepys MB, Hawkins PN. Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. J Clin Invest 1993;91:1351-7
31. U.S. Department of Health and Human Services. The Health Consequences of Involuntary Exposure to Tobacco Smoke. 2006
32. Panagiotakos DB, Pitsavos C, Chrysohoou C, Skoumas J, Masoura C, Toutouzas P et al. Effect of exposure to secondhand smoke on markers of inflammation: the ATTICA study. Am J Med 2004;116:145-50
33. Moschos N, Christoforaki M, Antonatos P. Seasonal distribution of acute myocardial infarction and its relation to acute infections in a mild climate. Int J Cardiol 2004;93:39-44
34. Spencer FA, Goldberg RJ, Becker RC, Gore JM. Seasonal distribution of acute myocardial infarction in the second National Registry of Myocardial Infarction. J Am Coll Cardiol 1998;31:1226-33
35. Sung KC. Seasonal variation of C-reactive protein in apparently healthy Koreans. Int J Cardiol 2006;107:338-42
36. Frohlich M, Sund M, Thorand B, Hutchinson WL, Pepys MB, Koenig W. Lack of seasonal variation in C-reactive protein. Clin Chem 2002;48:575-7
37. Wang AY, Woo J, Lam CW, Wang M, Sea MM, Lui SF et al. Is a single time point C-reactive protein predictive of outcome in peritoneal dialysis patients? J Am Soc Nephrol 2003;14:1871-9